CLINICAL_TRIALS
trial_result
· 2017-04-10
Clinical Trial Update: Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old [Phase 3]
Summary
Phase 3 safety study of a herpes simplex vaccine in HSV seronegative and seropositive females aged 10-17 completed; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Herpes Simplex | Phase 3 | Status: COMPLETED | Results posted: 2017-04-10